AbstractTwo human monoclonal anti-HIV-1 antibodies, 2F5 and 4E10, were utilized to investigate the accessibility and conservation of gp41 MPER epitopes on five different clades of HIV-1 in the absence and presence of sCD4. The binding of human monoclonal antibodies (mAbs) to HIV-1 was dependent upon the virus clade. Soluble CD4 significantly increased the accessibility of gp41 MPER-binding epitopes on several isolates that previously showed little or no binding with 2F5 and 4E10 mAbs as determined by a modified ELISA-based virus capture assay and surface plasmon resonance. Studies on the relationship between virus binding and neutralization in a TZM-bl pseudovirus assay indicated that in most cases, mAbs that exhibited neutralization also b...
Broadly cross-reactive human immunodeficiency virus (HIV)-neutralizing antibodies are infrequently e...
Human immunodeficiency virus (HIV-1) enters target cells by binding its gp120 exterior envelope glyc...
HIV-1 neutralizing monoclonal antibodies (MAbs) define key targets for vaccine development and are b...
We have used cells infected with the HIV-1 molecular clone HX10 to study the binding of monoclonal a...
AbstractThe binding of the human immunodeficiency virus type 1(HIV-1) envelope glycoprotein, gp120, ...
AbstractHuman immunodeficiency virus (HIV-1) enters target cells by binding its gp120 exterior envel...
Abstract Background The CD4-induced (CD4i) epitopes in gp120 includes the co-receptor binding site, ...
The entry of human immunodeficiency virus (HIV-1) into target cells typically requires the sequentia...
The envelope glycoproteins of HIV, gp120 and gp41, contain epitopes recognized by neutralizing antib...
Identification of broadly cross-reactive HIV-1-neutralizing antibodies (bnAbs) may assist vaccine im...
Anti-human immunodeficiency virus type 1 (HIV-1) antibodies whose binding to gp120 is enhanced by CD...
AbstractUsing immunobiochemical approaches we previously studied the conformation and surface exposu...
AbstractWe have used cells infected with the HIV-1 molecular clone HX10 to study the binding of mono...
AbstractTo better understand the limits of antigenic reactivity and epitope accessibility of the V3 ...
A subset of the neutralizing anti-HIV antibodies recognize epitopes on the envelope protein gp120 of...
Broadly cross-reactive human immunodeficiency virus (HIV)-neutralizing antibodies are infrequently e...
Human immunodeficiency virus (HIV-1) enters target cells by binding its gp120 exterior envelope glyc...
HIV-1 neutralizing monoclonal antibodies (MAbs) define key targets for vaccine development and are b...
We have used cells infected with the HIV-1 molecular clone HX10 to study the binding of monoclonal a...
AbstractThe binding of the human immunodeficiency virus type 1(HIV-1) envelope glycoprotein, gp120, ...
AbstractHuman immunodeficiency virus (HIV-1) enters target cells by binding its gp120 exterior envel...
Abstract Background The CD4-induced (CD4i) epitopes in gp120 includes the co-receptor binding site, ...
The entry of human immunodeficiency virus (HIV-1) into target cells typically requires the sequentia...
The envelope glycoproteins of HIV, gp120 and gp41, contain epitopes recognized by neutralizing antib...
Identification of broadly cross-reactive HIV-1-neutralizing antibodies (bnAbs) may assist vaccine im...
Anti-human immunodeficiency virus type 1 (HIV-1) antibodies whose binding to gp120 is enhanced by CD...
AbstractUsing immunobiochemical approaches we previously studied the conformation and surface exposu...
AbstractWe have used cells infected with the HIV-1 molecular clone HX10 to study the binding of mono...
AbstractTo better understand the limits of antigenic reactivity and epitope accessibility of the V3 ...
A subset of the neutralizing anti-HIV antibodies recognize epitopes on the envelope protein gp120 of...
Broadly cross-reactive human immunodeficiency virus (HIV)-neutralizing antibodies are infrequently e...
Human immunodeficiency virus (HIV-1) enters target cells by binding its gp120 exterior envelope glyc...
HIV-1 neutralizing monoclonal antibodies (MAbs) define key targets for vaccine development and are b...